University of California, Davis

Chemomab to Host Virtual Key Opinion Leader Webinar on Primary Sclerosing Cholangitis on April 10, 2024

Retrieved on: 
Tuesday, April 2, 2024
Q&A, Primary sclerosing cholangitis, Liver disease, UC, UPMC, KOL, PSC, Doctor of Philosophy, Digestate, CCL24, Clinical trial, Therapy, CMMB, Liver, University of California, Davis, FDA, TEL, Pharmaceutical industry

TEL AVIV, Israel, April 02, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics to treat rare fibro-inflammatory diseases with high unmet need, today announced it will host a live key opinion leader (KOL) virtual event on primary sclerosing cholangitis (PSC) on Wednesday, April 10, 2024 at 10:00 AM ET. To register, click here.

Key Points: 
  • —“Breaking New Ground: Expert Perspectives on Primary Sclerosing Cholangitis” Will Feature Clinical, Academic and Patient Advocacy Leaders Discussing PSC Disease Management and Evolving Views on Clinical Development—
    TEL AVIV, Israel, April 02, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics to treat rare fibro-inflammatory diseases with high unmet need, today announced it will host a live key opinion leader (KOL) virtual event on primary sclerosing cholangitis (PSC) on Wednesday, April 10, 2024 at 10:00 AM ET.
  • They will discuss the urgent need for new PSC treatments and emerging developments that could facilitate new drug approvals.
  • Chemomab’s co-founder, CEO & CSO Adi Mor, PhD and CMO Matt Frankel, MD, will provide an overview of the CM-101 Phase 2 PSC clinical trial that will report topline results midyear 2024.
  • CM-101 is a dual mechanism first-in-class monoclonal antibody that neutralizes CCL24, a soluble protein that is a key driver of inflammatory and fibrotic pathways central to PSC and other fibro-inflammatory diseases.

Veteran Patient Experience Executive Jennifer Baron Joins NRC Health as Its First Chief Experience Officer

Retrieved on: 
Tuesday, April 2, 2024
Professional Services, Health, Data Analytics, Hospitals, Practice Management, Health Technology, Managed Care, Baron, Ball State University, Indiana University Health, NRC, Patient, Knowledge, UC, University, Ball, Faculty, Human, National Research Corporation, Investment, University of California, Davis, Multimedia, Nursing

NRC Health, a recognized leader providing solutions and data driven insights for improving health care experiences, announced today the appointment of Jennifer Baron as the organization’s first chief experience officer.

Key Points: 
  • NRC Health, a recognized leader providing solutions and data driven insights for improving health care experiences, announced today the appointment of Jennifer Baron as the organization’s first chief experience officer.
  • View the full release here: https://www.businesswire.com/news/home/20240402975173/en/
    “For health systems, ensuring an excellent patient experience is a core component of providing quality care and services,” says Baron.
  • Baron – a veteran health system experience executive and advocate for centering patient and employee voices – has a keen understanding of both the challenges and opportunities for health systems in delivering quality patient experiences.
  • Baron joins NRC Health from UC Davis Health, where she served as chief experience officer since 2020.

Ivy Fertility Hires Dr. Bryn Willson and Dr. Shelun Tsai

Retrieved on: 
Thursday, March 21, 2024
Baby, Maternity, Managed Care, Other Health, Health, Women, Other Science, Research, Hospitals, Genetics, Consumer, Science, Cedars-Sinai Medical Center, Education, Weill Cornell Medicine, SDFC, Patient, Duke University, UC, University, Weill Cornell Medical Center, MD, Pacific coast, Infertility, Gynaecology, Harvard University, University of California, Davis, Santa Clara University, Golden apple, Obstetrics, Duke, Physician, Hedera

Ivy Fertility, a collaborative network of globally-renowned fertility clinics, is thrilled to welcome Bryn Willson, MD and Shelun Tsai, MD to its collaborative team of physicians.

Key Points: 
  • Ivy Fertility, a collaborative network of globally-renowned fertility clinics, is thrilled to welcome Bryn Willson, MD and Shelun Tsai, MD to its collaborative team of physicians.
  • Dr. Willson and Dr. Tsai are both board-certified in obstetrics and gynecology, and will complete their fellowships in reproductive endocrinology this spring.
  • “The entire Ivy Fertility network is committed to staying at the forefront of fertility science,” said Sandy Chuan, MD, Medical Director at San Diego Fertility Center.
  • “We are privileged that Dr. Willson and Dr. Tsai will be contributing their innovation and compassion to our network.”

University of California, Davis Student Receives SBB Research Group Foundation STEM Scholarship

Retrieved on: 
Wednesday, April 3, 2024
Learning, Genetics, UC, Ophthalmology, Research, University, Student, STEM, Genomics, Progressive retinal atrophy, University of California, Davis, Nursing

CHICAGO, April 3, 2024 /PRNewswire-PRWeb/ -- The SBB Research Group Foundation named Meher Khan a recipient of its STEM scholarship. The $2,500 award empowers students to create value for society by pursuing higher learning through interdisciplinary combinations of Science, Technology, Engineering, and Mathematics (STEM).

Key Points: 
  • CHICAGO, April 3, 2024 /PRNewswire-PRWeb/ -- The SBB Research Group Foundation named Meher Khan a recipient of its STEM scholarship.
  • The $2,500 award empowers students to create value for society by pursuing higher learning through interdisciplinary combinations of Science, Technology, Engineering, and Mathematics (STEM).
  • Meher Khan, a sophomore, studies Genetics and Genomics at the University of California, Davis.
  • We are proud to support that future," said Matt Aven, co-founder and board member of the SBB Research Group Foundation.

Cellenkos® enters into Sponsored Research Agreement with Icahn School of Medicine at Mount Sinai, New York.

Retrieved on: 
Monday, April 1, 2024
Research, Pacritinib, JAK2, Bone marrow, Blood transfusion, CXCR4, Inflammation, Patient, University, Ruxolitinib, Clinical trial, CXCL12, Fedratinib, Safety, Pancreatic serous cystadenoma, University of California, Davis, MD Anderson Cancer Center, Albert Einstein Israelite Hospital, Pharmaceutical industry

Research exploring CK0804 (CXCR4-enriched, allogeneic, cord blood-derived T-regulatory cells) for treatment of myelofibrosis patients.

Key Points: 
  • Research exploring CK0804 (CXCR4-enriched, allogeneic, cord blood-derived T-regulatory cells) for treatment of myelofibrosis patients.
  • This research will be conducted under the guidance of Ronald Hoffman, MD, Albert A. and Vera G. List Professor of Medicine and Director of the Myeloproliferative Disorders Research Program at The Tisch Cancer Institute- Mount Sinai.
  • CK0804 is a novel allogeneic, CXCR4 enriched, Treg cell therapy product that utilizes Cellenkos' proprietary CRANE® technology to generate disease specific products.
  • Dr. Ronald Hoffman serves as a paid consultant for Cellenkos.

UbiQD's Quantum Dot Greenhouse Technology Wins 2024 SXSW Innovation Award and U.S. Department of Agriculture SBIR Grant

Retrieved on: 
Tuesday, March 19, 2024
Physics, University of California, Davis, USDA, SXSW, SBIR, Service, The Economist, Fluorescence, Rest, University, Glass, LOS, WTF, Airline

LOS ALAMOS, N.M., March 19, 2024 /PRNewswire/ -- UbiQD, Inc., the New Mexico-based leader in quantum dot (QD) technology and manufacturing, announced today that it was named winner in the What the Future (WTF) category of the prestigious 25th Annual SXSW Innovation Awards competition, where the company showcased its new UbiGro® Cover greenhouse film product for enhancing crop yield using fluorescence.

Key Points: 
  • The South by Southwest ® (SXSW®) Innovation Awards recognize the most exciting creative developments in the connected world, celebrating a variety of technological advancements, achievements, and discoveries.
  • From quantum physics to nanotech to bio-engineering moonshots, this category pulls together all the amazing endeavors that make us excited about tomorrow."
  • Later in the week, the United States Department of Agriculture (USDA) awarded UbiQD a Phase I Small Business Innovation and Research (SBIR) grant to develop a glass version of its award-winning UbiGro greenhouse technology.
  • The $175,000 grant will also support plant trials for the new QD-glass product at University of California-Davis later this year.

MARAbio appoints Gail S. Page as member of Board of Directors

Retrieved on: 
Thursday, March 14, 2024
Labcorp, Incidence, Physician, UC, Vermilion, Child, Pregnancy, Luminex, Water, MIND, University of California, Davis, Spectrum, Parent, Management

SALT LAKE CITY, March 14, 2024 /PRNewswire-PRWeb/ -- MARAbio, whose mission is to detect, treat, and prevent Maternal Autoantibody Related Autism (MARA), has appointed Gail S. Page to its Board of Directors. Ms. Page has more than 30 years of life sciences experience, and currently serves as a partner at pH Blueprint, a strategic advisory firm focused on collaborating with medical device, diagnostics, and biotech clients. She is also a Venture Partner at Turret Capital Management, a global healthcare investment and venture firm. Previously Ms. Page served in executive management roles with LabCorp and Roche Biomedical, as Chief Operating Officer at Luminex, and President & CEO of Vermillion, Inc. Her current and past board appointments include public and private companies.

Key Points: 
  • SALT LAKE CITY, March 14, 2024 /PRNewswire-PRWeb/ -- MARAbio , whose mission is to detect, treat, and prevent Maternal Autoantibody Related Autism (MARA), has appointed Gail S. Page to its Board of Directors.
  • She is also a Venture Partner at Turret Capital Management, a global healthcare investment and venture firm.
  • Page served in executive management roles with LabCorp and Roche Biomedical, as Chief Operating Officer at Luminex, and President & CEO of Vermillion, Inc.
  • "Gail brings significant insights and experience in the diagnostic and clinical lab sectors as a former CEO and other C-level positions, and we are very pleased to welcome her to MARAbio's Board of Directors," said Marnin Kligfeld, Chairman of the Board of MARAbio.

Verizon Business to demonstrate the impact of connected healthcare at ViVE 2024

Retrieved on: 
Thursday, February 22, 2024
Senior, FWA, MD, Internet of things, Health, Health care, UC, University of California, Davis, Verizon Communications, ViVe, Digital inclusion, Patient, Digital divide, Verizon Business, CX, Robotics, Nursing

BASKING RIDGE, N.J., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Verizon Business will showcase its healthcare solutions at ViVE 2024 (Booth #1510) at the Los Angeles Convention Center in Los Angeles this month.

Key Points: 
  • BASKING RIDGE, N.J., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Verizon Business will showcase its healthcare solutions at ViVE 2024 (Booth #1510) at the Los Angeles Convention Center in Los Angeles this month.
  • In 2024, healthcare providers will invest more in technology to enhance patient care, close the digital divide, and safeguard patient information.
  • "Verizon Business is working with leading healthcare enterprises to bridge the digital divide and bring equitable care to various patient populations,” said Scott Lawrence, Senior Vice President Global Solutions, Verizon Business.
  • To schedule a media briefing or a booth tour with an attending Verizon Business executive, please email [email protected] .

Cadiz Inc. Announces Appointment of Barbara Lloyd to its Board of Directors

Retrieved on: 
Friday, March 1, 2024
Public policy, Woman, LOS, Audit, Lloyd's of London, Compensation, Irvine Ranch Water District, California State Assembly, City, Water resources, Government, MBA, California High-Speed Rail, Treasury, Stanford University, Climate change, University, UC, University of California, Davis, Public finance, Barclays, Veterans' affairs, Transport, KPMG, Water, Financial services

LOS ANGELES, March 1, 2024 /PRNewswire/ -- Cadiz, Inc. (NASDAQ: CDZI / CDZIP, the "Company") announced that Barbara Lloyd, a leading professional in the project finance industry with deep experience in public-private infrastructure financing in California, was appointed today to the Company's Board of Directors.

Key Points: 
  • "Cadiz will be the first Company in the world to convert natural gas pipelines for water conveyance.
  • Lloyd's appointment filled an existing vacancy on the Cadiz Board and is effective immediately.
  • The Board also appointed Lloyd to serve on the Audit & Risk and Compensation committees.
  • The appointment of Lloyd makes the Cadiz Board a majority women directors for the first time in the Company's history.

United Imaging Showcases AI-Driven Innovations and Expands European Presence at ECR 2024

Retrieved on: 
Friday, February 23, 2024
One Solution, UAI, ACS, Growth, Abdomen, Radiology, Perception, Bionics, Pelvis, SAT, University, ECR, Diagnosis, UMR, Neurology, Robotics, MRI, Software, CARE, CE, 3D, Radio, Extrapyramidal system, Brain, UII, SCAN, Safety, UDP, Yale University, Research, Workflow, Philosophy, MSK, 2D, Umi, AI, Cardiology, Thought, Signal-to-noise ratio, Joint, UC, University of California, Davis, Patient, DSA, Medical device

VIENNA, Feb. 23, 2024 /PRNewswire/ -- United Imaging, a global leader in medical technology, is showcasing its full portfolio of AI-empowered innovations at the European Society of Radiology (ECR) 2024 in Vienna, Austria.

Key Points: 
  • VIENNA, Feb. 23, 2024 /PRNewswire/ -- United Imaging, a global leader in medical technology, is showcasing its full portfolio of AI-empowered innovations at the European Society of Radiology (ECR) 2024 in Vienna, Austria.
  • At United Imaging, all our innovations are AI-driven, enhancing clinical workflows and supporting diverse scenarios, solidifying our commitment to delivering value to the global medical community.
  • In five years, United Imaging has introduced hundreds of systems and reached 16 European countries, offering efficient and professional service.
  • Highlighting the growth at ECR 2024, United Imaging will feature the uMR Jupiter 5T (not CE marked in EU) at ECR 2024, a revolutionary whole-body 5T MRI system.